| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.31 | 0.06 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.27 | 0.08 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.25 | 0.09 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.2 | 0.2 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.18 | 0.03 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |